HMN trades 30.4% below Wall Street's consensus target of $59.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HMN achieves its forward estimates and maintains a stable P/E multiple of 9.3x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Horace Mann Educators Corporation (HMN) has a Wall Street consensus price target of $59.00, based on estimates from 9 covering analysts. With the stock currently trading at $45.26, this represents a potential upside of +30.4%. The company has a market capitalization of $1.83B.
Analyst price targets range from a low of $59.00 to a high of $59.00, representing a 0% spread in expectations. The median target of $59.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, HMN trades at a trailing P/E of 11.6x and forward P/E of 9.3x. The forward PEG ratio of 2.39 reflects a premium valuation. Analysts expect EPS to grow +12.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $60.97, with bear and bull scenarios of $38.41 and $80.33 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AFLAflac Incorporated | $56.8B | $111.54 | $118.86 | +6.6% | Hold | 15.9x | 32 |
 CNOCNO Financial Group, Inc. | $5.0B | $53.86 | $57.67 | +7.1% | Hold | 11.4x | 17 |
 GLGlobe Life Inc. | $12.9B | $165.68 | $183.00 | +10.5% | Hold | 10.5x | 28 |
 FGF&G Annuities & Life, Inc. | $2.9B | $21.92 | $32.00 | +46.0% | Hold | 6.8x | 9 |
 METMetLife, Inc. | $60.8B | $94.43 | $103.22 | +9.3% | Buy | 9.3x | 33 |
 PRUPrudential Financial, Inc. | $39.1B | $112.60 | $105.22 | -6.6% | Hold | 7.8x | 37 |
 LNCLincoln National Corporation | $7.7B | $40.30 | $46.00 | +14.1% | Hold | 5.1x | 28 |
 UNMUnum Group | $14.0B | $88.57 | $101.13 | +14.2% | Buy | 10.2x | 30 |
 PFGPrincipal Financial Group, Inc. | $24.2B | $111.96 | $109.00 | -2.6% | Hold | 11.7x | 25 |
 VOYAVoya Financial, Inc. | $8.8B | $96.65 | $104.22 | +7.8% | Buy | 10.6x | 27 |
Quick answers to the most common questions about buying HMN stock.
The consensus Wall Street price target for HMN is $59, representing 30.4% upside from the current price of $45.26. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HMN has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $59 implies 30.4% upside from current levels.
With a forward P/E of 9.3397x, HMN trades at a relatively low valuation. The consensus target of $59 implies 30.4% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $59 for HMN, while the most conservative target is $59. The consensus of $59 represents the median expectation. Our quantitative valuation model projects a bull case target of $80 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HMN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 3 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HMN stock forecast based on 9 Wall Street analysts shows a consensus price target of $59, with estimates ranging from $59 (bear case) to $59 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $61, with bear/bull scenarios of $38/$80.
Our quantitative valuation model calculates HMN's fair value at $61 (base case), with a bear case of $38 and bull case of $80. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
HMN trades at a forward P/E ratio of 9.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HMN, with a "Hold" consensus rating and $59 price target (30.4% upside). 4 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HMN analyst price targets range from $59 to $59, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $59 consensus represents the middle ground. Our model's $38-$80 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.